These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29575534)

  • 21. Fractures in children with Pompe disease: a potential long-term complication.
    Case LE; Hanna R; Frush DP; Krishnamurthy V; DeArmey S; Mackey J; Boney A; Morgan C; Corzo D; Bouchard S; Weber TJ; Chen YT; Kishnani PS
    Pediatr Radiol; 2007 May; 37(5):437-45. PubMed ID: 17342521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach.
    Ing RJ; Cook DR; Bengur RA; Williams EA; Eck J; Dear Gde L; Ross AK; Kern FH; Kishnani PS
    Paediatr Anaesth; 2004 Jun; 14(6):514-9. PubMed ID: 15153218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy and associated events in women receiving enzyme replacement therapy for late-onset glycogen storage disease type II (Pompe disease).
    Rohman PJ; Scott E; Richfield L; Ramaswami U; Hughes DA
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1263-1271. PubMed ID: 27384519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy.
    van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA
    Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Juvenile Pompe disease: retrospective clinical study].
    Loureiro Neves F; Garcia PC; Madureira N; Araújo H; Rodrigues F; Estêvão MH; Lacerda L; Diogo Matos LM
    Acta Med Port; 2013; 26(4):361-70. PubMed ID: 24016645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy.
    Cho A; Kim SJ; Lim BC; Hwang H; Park JD; Kim GB; Jin DK; Lee J; Ki CS; Kim KJ; Hwang YS; Chae JH
    J Child Neurol; 2012 Mar; 27(3):319-24. PubMed ID: 21940687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of muscle pathology in infantile Pompe disease.
    Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
    Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
    Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
    Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term enzyme replacement therapy for pompe disease with recombinant human alpha-glucosidase derived from chinese hamster ovary cells.
    Rossi M; Parenti G; Della Casa R; Romano A; Mansi G; Agovino T; Rosapepe F; Vosa C; Del Giudice E; Andria G
    J Child Neurol; 2007 May; 22(5):565-73. PubMed ID: 17690063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative mortality related to anesthesia within 48 h and up to 30 days following surgery: A retrospective cohort study of 11,562 anesthetic procedures.
    Stefani LC; Gamermann PW; Backof A; Guollo F; Borges RMJ; Martin A; Caumo W; Felix EA
    J Clin Anesth; 2018 Sep; 49():79-86. PubMed ID: 29909205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase.
    van Capelle CI; Poelman E; Frohn-Mulder IM; Koopman LP; van den Hout JMP; Régal L; Cools B; Helbing WA; van der Ploeg AT
    Int J Cardiol; 2018 Oct; 269():104-110. PubMed ID: 30049495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrio-ventricular block requiring pacemaker in patients with late onset Pompe disease.
    Sacconi S; Wahbi K; Theodore G; Garcia J; Salviati L; Bouhour F; Vial C; Duboc D; Laforêt P; Desnuelle C
    Neuromuscul Disord; 2014 Jul; 24(7):648-50. PubMed ID: 24844452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy.
    Terzis G; Krase A; Papadimas G; Papadopoulos C; Kavouras SA; Manta P
    Mol Genet Metab; 2012 Dec; 107(4):669-73. PubMed ID: 23146291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ten years of the international Pompe survey: patient reported outcomes as a reliable tool for studying treated and untreated children and adults with non-classic Pompe disease.
    van der Meijden JC; Güngör D; Kruijshaar ME; Muir AD; Broekgaarden HA; van der Ploeg AT
    J Inherit Metab Dis; 2015 May; 38(3):495-503. PubMed ID: 25112389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Pompe disease in a Portuguese high risk population.
    Almeida V; Conceição I; Fineza I; Coelho T; Silveira F; Santos M; Valverde A; Geraldo A; Maré R; Aguiar TC; Mendonça C; Martins J; Medeiros L; Barroso C; Vieira JP; Moreno T; Negrão L; Dias MS; Lacerda L; Evangelista T
    Neuromuscul Disord; 2017 Aug; 27(8):777-781. PubMed ID: 28554557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy.
    Katzin LW; Amato AA
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities.
    van der Beek NA; Soliman OI; van Capelle CI; Geleijnse ML; Vletter WB; Kroos MA; Reuser AJ; Frohn-Mulder IM; van Doorn PA; van der Ploeg AT
    J Neurol Sci; 2008 Dec; 275(1-2):46-50. PubMed ID: 18757064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Children with heart disease: Risk stratification for non-cardiac surgery.
    Saettele AK; Christensen JL; Chilson KL; Murray DJ
    J Clin Anesth; 2016 Dec; 35():479-484. PubMed ID: 27871578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile Pompe disease with intrauterine onset: a case report and literature review.
    Xi H; Li X; Ma L; Yin X; Yang P; Zhang L
    Ital J Pediatr; 2022 Nov; 48(1):187. PubMed ID: 36411466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease.
    Nilsson MI; Samjoo IA; Hettinga BP; Koeberl DD; Zhang H; Hawke TJ; Nissar AA; Ali T; Brandt L; Ansari MU; Hazari H; Patel N; Amon J; Tarnopolsky MA
    Mol Genet Metab; 2012 Nov; 107(3):469-79. PubMed ID: 23041258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.